Advertisement

Topics

Theravance Biopharma Reports Encouraging Data from First Cohort of Patients in Phase 1b ...

16:05 EDT 8 Aug 2017 | BioMedReports - Blog

The Phase 1b exploratory study is designed to evaluate the safety, tolerability, and pharmacokinetics (PK) of TD-1473 over a 28-day treatment period. In addition, the

Read more...

Original Article: Theravance Biopharma Reports Encouraging Data from First Cohort of Patients in Phase 1b ...

NEXT ARTICLE

More From BioPortfolio on "Theravance Biopharma Reports Encouraging Data from First Cohort of Patients in Phase 1b ..."

Quick Search
Advertisement